Ucar, CCaliskan, U2020-03-262020-03-2620060888-0018https://dx.doi.org/10.1080/08880010600631987https://hdl.handle.net/20.500.12395/20686L-Asparaginase, a major component of therapy in children with acute lymphoblastic leukemia, has been shown to induce coagulopathy by inhibiting synthesis of clot-forming and clot- inhibitory proteins. The authors report the successful use of recombinant factor VIIa in a 15-year-old girl with acute lymphoblastic leukemia who had L-asparaginase-induced intracranial hemorrhage. The present case is the first to demonstrate use of rFVIIa in L-asparaginase-induced intracranial hemorrhage in a child with acute lymphoblastic leukemia.en10.1080/08880010600631987info:eu-repo/semantics/closedAccessacute lymphoblastic leukemiaactivated recombinant factor VIIachildintracranial hemorrhageL-asparaginaseArticle23433934516621776Q3WOS:000237849000009Q4